Sunday, May 19, 2024
Facebook Linkedin Twitter
HomeTagsGenentech

Genentech

Healthcare

Genentech’s BTK Inhibitor Fenebrutinib Significantly Reduced Brain Lesions in People With Relapsing Forms of Multiple Sclerosis

Business Wire -
Genentech, a member of the Roche Group , announced positive results from the Phase II FENopta study evaluating investigational oral fenebrutinib in adults with...
Healthcare

PicnicHealth Announces Continued Real-World Data Strategic Partnership with Roche and Genentech to Advance Neurological Disease Research

Business Wire -
PicnicHealth, a patient-centered health technology company, announced its intent to globally expand its partnership with Roche and Genentech to accelerate neurological disease research through...
Biotechnology

FDA Approves Genentech’s Polivy in Combination With R-CHP for People With Certain Types of Previously Untreated Diffuse Large B-cell Lymphoma

Business Wire -
Genentech, a member of the Roche Group, announced that the U.S. Food and Drug Administration (FDA) has approved Polivy in combination with Rituxan, cyclophosphamide,...
Healthcare

Genentech’s Tecentriq Plus Avastin Reduced the Risk of Cancer Returning in People With Certain Types of Adjuvant Liver Cancer in a Phase III Study

Business Wire -
Genentech, a member of the Roche Group, announced new data from the Phase III IMbrave050 study that show Tecentriq plus Avastin demonstrated a statistically significant...
Healthcare

Genentech Announces Positive Data From Global Phase III Program for Crovalimab in PNH, a Rare, Life-Threatening Blood Condition

Business Wire -
Genentech, a member of the Roche Group announced positive results from the global Phase III COMMODORE 2 study, evaluating the efficacy and safety of...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics

Load more
ReadMagazine © | All rights reserved |Contact Us | Privacy Policy| Become A Guest Writer | Advertise with Us